1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. REMUS PHARMACEUTICALS LTD.
Remus Pharmaceuticals Ltd.
NSE: REMUS
Ask AI about Remus Pharma
807.9012.90(1.62%)
700
NSE Volume

NSE 20 Nov, 2026 11:53 AM

Portfolio

Alert

My Notes

Remus Pharma quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Remus Pharma competitor comparison and performance snapshot within industry

Remus Pharma annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

  • POSITIVE

    Annual Revenue Remus Pharma Mar-2026 Annual Revenue is Rs 101 Cr which is growth of 22.9% YoY.

  • POSITIVE

    Annual Net Profit Remus Pharma Mar-2026 Annual Net Profit is Rs 25 Cr which is growth of 24.2% YoY.

Remus Pharmaceuticals Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
IndicatorGraphCAGR 3 YrsCAGR 5 YrsMar '26Mar '25Mar '24Mar '23Mar '22Mar '21Mar '20
29.3%
39.3%
100.882.167.246.625.419.212.8
Operating Exp. Ann.
23.1%
29.4%
64.353.243.534.520.717.711.5
Operating Profit Ann.
41%
106%
29.7262010.64.10.80.4
OPM Ann. %
9.2%
49.4%
29.48%31.66%29.83%22.63%16.00%3.96%3.07%
⌄
24.3%
30.4%
67.655.444.735.220.917.911.7
EBITDA Ann.
44.6%
87%
36.628.923.712.14.81.61.2
EBITDA Ann. margin %
11.7%
34.8%
36.26%35.20%35.33%26.01%18.83%8.16%9.73%
Interest Ann.
44.2%
-
0.60.40.30.20.100
Depr.
77.6%
69.5%
2.81.90.90.50.20.20.1
PBT Ann.
42.8%
88.4%
33.226.622.511.44.61.41.1
Tax Ann.
43.1%
95.2%
8.56.75.72.91.20.30.3
42.7%
89.9%
24.719.916.88.53.410.8
Net Profit Ann.
42.7%
89.9%
24.719.916.88.53.410.8
NPM Ann. %
11.7%
36.4%
26.29%25.13%26.48%18.88%13.69%5.56%6.80%
EPS Adj. latest Ann.
42.9%
87.8%
2116.914.37.22.90.90.7
*All financials are in INR Cr and price data in INR
Total Rev. Ann.
1Y CHG
22.8%
2Y CAGR
22.5%
3Y CAGR
29.3%
5Y CAGR
39.3%
Net Profit Ann.
1Y CHG
24.1%
2Y CAGR
21.3%
3Y CAGR
42.7%
5Y CAGR
89.9%
Operating Exp. Ann.
1Y CHG
20.9%
2Y CAGR
21.6%
3Y CAGR
23.1%
5Y CAGR
29.4%

Remus Pharma balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history

  • POSITIVE

    Total Shareholders Fund Remus Pharma Mar-2026 Total Shareholders Fund is Rs 326 Cr which is growth of 34.5% YoY.

  • POSITIVE

    Total Assets Remus Pharma Mar-2026 Total Assets is Rs 382 Cr which is growth of 36.3% YoY.

Remus Pharmaceuticals Ltd., Balance Sheet, standalone, All financials are in INR Cr and price data in INR
IndicatorGraphCAGR 3 YrsCAGR 5 YrsMar '26Mar '25Mar '24Mar '23Mar '22Mar '21Mar '20
⌄
157.4%
153.7%
325.7242.282.119.16.43.12
Minority Interest Liability Ann.
-
-
-------
⌄
73.3%
164%
38.5271.77.40.30.30.4
29.2%
18.1%
17.711.114.38.29.27.72.9
Total Capital Plus Liabilities Ann.
122.4%
102.9%
381.9280.398.134.715.911.15.3
⌄
41.7%
79.2%
7.47.12.32.60.30.40.5
⌄
133.9%
141.9%
298.3226.446.923.38.23.60.5
94.9%
62%
83.653.951.211.37.77.54.8
Total Assets Ann.
122.4%
102.9%
381.9280.398.134.715.911.15.3
Contingent Liabilities plus Commitments Ann.
-
-
0.37694.4
Bonus Equity Share Capital Ann.
79.7%
-
5.85.81.411
Non Current Investments Unquoted Book Value Ann.
3.4%
-
22.822.743.120.63.1
Current Investments Unquoted Book Value Ann.
-
-
*All financials are in INR Cr and price data in INR
Total Assets Ann.
1Y CHG
36.2%
2Y CAGR
97.3%
3Y CAGR
122.4%
5Y CAGR
102.9%
Total Current Liabilities Ann.
1Y CHG
59.5%
2Y CAGR
11.3%
3Y CAGR
29.2%
5Y CAGR
18.1%
Total ShareHolders Funds Ann.
1Y CHG
34.5%
2Y CAGR
99.2%
3Y CAGR
157.4%
5Y CAGR
153.7%

Remus Pharma ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history

  • NEGATIVE

    Book Value Per Share Remus Pharma Mar-2026 Book Value Per Share is 276 Rs which is growth of -32.8% YoY.

  • POSITIVE

    ROE Remus Pharma Mar-2026 ROE is 8% which is growth of 0.6% YoY.

Remus Pharmaceuticals Ltd., Ratios, standalone, All financials are in INR Cr and price data in INR
IndicatorGraphCAGR 3 YrsCAGR 5 YrsMar '26Mar '25Mar '24Mar '23Mar '22Mar '21Mar '20
BVSH Ann.
16.2%
-38.1%
276.5411.2557.1176.464.33,046.12,020.3
RoA Ann. %
-35.9%
-7%
6.46%7.09%17.15%24.53%21.28%9.28%15.30%
ROE Ann. %
-44.5%
-25.8%
7.58%8.21%20.49%44.43%52.64%33.67%40.17%
ROCE Ann. %
-40.4%
-25.9%
9.28%10.03%27.27%43.94%69.08%41.48%47.78%
⌄
       
⌄
       
⌄
       
Total Debt to Total Equity Ann.
-
-
0000.400.10.2
*All financials are in INR Cr and price data in INR
ROE Ann. %
1Y CHG
-7.7%
2Y CAGR
-39.2%
3Y CAGR
-44.5%
5Y CAGR
-25.8%
RoA Ann. %
1Y CHG
-8.9%
2Y CAGR
-38.6%
3Y CAGR
-35.9%
5Y CAGR
-7%
Current Ratio Ann.
1Y CHG
-4.1%
2Y CAGR
14.3%
3Y CAGR
49.7%
5Y CAGR
36.3%

Remus Pharma cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history

  • NEUTRAL

    Cash From Operating Activity Remus Pharma Mar-2026 Cash From Operating Activity is Rs 0 Cr which is growth of 0% YoY.

  • NEGATIVE

    Net Cash Flow Remus Pharma Mar-2026 Net Cash Flow is Rs 0 Cr which is growth of -100.0% YoY.

Remus Pharmaceuticals Ltd., Cash Flow, standalone, All financials are in INR Cr and price data in INR
IndicatorGraphCAGR 3 YrsCAGR 5 YrsMar '26Mar '25Mar '24Mar '23Mar '22Mar '21Mar '20
46.1%
64.4%
15.62.45.352.81.3
Cash from Investing Act. Ann.
-
-
-12.4-20.9-15.2-4.6-3.1-0.6
Cash from Financing Act. Ann.
-
-
-1.439.311.8-0.2-0.10.1
81.7%
17.6%
1.820.81.90.3-0.40.8
*All financials are in INR Cr and price data in INR
Cash from Operating Act. Ann.
1Y CHG
550%
2Y CAGR
71.6%
3Y CAGR
46.1%
5Y CAGR
64.4%

Remus Pharma investor presentations, annual reports, credit ratings, and earnings calls with AI summary, video, and audio access